Log in to save to my catalogue

Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-T...

Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-T...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A832237973

Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-[beta]1 signaling mechanism

About this item

Full title

Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-[beta]1 signaling mechanism

Publisher

BioMed Central Ltd

Journal title

Journal of experimental & clinical cancer research, 2025-03, Vol.44 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background Prostate cancer (PCa) is the second most common type of tumor diagnosed in men and the fifth leading cause of cancer-related death in male patients. The response of metastatic disease to standard treatment is heterogeneous. As for now, there is no curative treatment option available for metastatic PCa, and the clinical tests capable of p...

Alternative Titles

Full title

Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-[beta]1 signaling mechanism

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A832237973

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A832237973

Other Identifiers

ISSN

0392-9078

DOI

10.1186/s13046-025-03299-6

How to access this item